Literature DB >> 24797782

Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.

Seung-Ju Yang1, Woo Je Lee2, Eun-A Kim3, Kee Dal Nam4, Hoh-Gyu Hahn4, Soo Young Choi5, Sung-Woo Cho6.   

Abstract

Thiazole derivatives are attractive candidates for drug development because they can be efficiently synthesized and are active against a number of diseases and conditions, including diabetes. In our present study, we investigated the anti-inflammatory and antioxidant properties of N-adamantyl-4-methylthiazol-2-amine (KHG26693), a new thiazole derivative, in a streptozotocin (STZ)-induced model of diabetes mellitus. STZ-induced diabetic rats were intraperitoneally administered KHG26693 (3mg/kg-body weight/day) for 4 weeks. KHG26693 administration significantly decreased blood glucose, triglycerides, and cholesterol and increased insulin. KHG26693 also suppressed several inflammatory responses in STZ-induced diabetic rats, as evidenced by decreased levels of serum tumor necrosis factor-α, interleukin-1β, and nitric oxide. Additionally, KHG26693 significantly modulated hepatic lipid peroxidation, catalase and superoxide dismutase activity, and the nonenzymatic antioxidant status (e.g., vitamins C and E), and reduced the glutathione content. These anti-inflammatory/antioxidative actions occurred as a result of the downregulation of inducible nitric oxide synthase and nuclear factor-kappa B. Taken together, our results suggest that KHG26693 successfully reduces the production of oxidative stress in STZ-induced diabetic rats by regulating the oxidation-reduction system, specifically increasing antioxidant capacity. Furthermore, KHG26693 treatment significantly reverted the key enzymes of glucose metabolism, such as glucokinase, glucose-6-phosphatase, glycogen synthase, glycogen phosphorylase, and fructose-1,6-bisphosphatase, to near-normal levels in liver tissues. These results indicate that KHG26693 normalizes disturbed glucose metabolism by enhancing glucose utilization and decreasing liver glucose production via insulin release, suggesting the possibility of future diabetes treatments.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antioxidant; Diabetes; Inflammation; Oxidative stress; Thiazole derivative

Mesh:

Substances:

Year:  2014        PMID: 24797782     DOI: 10.1016/j.ejphar.2014.04.031

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents.

Authors:  Mohammed F Arshad; Aftab Alam; Abdullah Ayed Alshammari; Mohammed Bader Alhazza; Ibrahim Mohammed Alzimam; Md Anish Alam; Gulam Mustafa; Md Salahuddin Ansari; Abdulelah M Alotaibi; Abdullah A Alotaibi; Suresh Kumar; Syed Mohammed Basheeruddin Asdaq; Mohd Imran; Pran Kishore Deb; Katharigatta N Venugopala; Shahamah Jomah
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

2.  N-Adamantyl-4-Methylthiazol-2-Amine Attenuates Glutamate-Induced Oxidative Stress and Inflammation in the Brain.

Authors:  Seung-Ju Yang; Eun-A Kim; Min-Jun Chang; Jiae Kim; Jung-Min Na; Soo Young Choi; Sung-Woo Cho
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

3.  Altered retinol status and expression of retinol-related proteins in streptozotocin-induced type 1 diabetic model rats.

Authors:  Kimitaka Takitani; Keisuke Inoue; Maki Koh; Hiroshi Miyazaki; Akiko Inoue; Kanta Kishi; Hiroshi Tamai
Journal:  J Clin Biochem Nutr       Date:  2015-01-28       Impact factor: 3.114

4.  Therapeutic Effects of Bupleurum Polysaccharides in Streptozotocin Induced Diabetic Mice.

Authors:  Lingyu Pan; Hongbo Weng; Hong Li; Zhenzhen Liu; Yanyan Xu; Chunjiao Zhou; Xiaoxiao Lu; Xiaoyu Su; Yunyi Zhang; Daofeng Chen
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

5.  Comparison of the response using ICR mice derived from three different sources to multiple low-dose streptozotocin-induced diabetes mellitus.

Authors:  Do Yeon Lee; Myeong Hwan Kim; Hye Rin Suh; Young Suk Jung; Dae Youn Hwang; Kil Soo Kim
Journal:  Lab Anim Res       Date:  2017-06-30

6.  N-Adamantyl-4-methylthiazol-2-amine suppresses glutamate-induced autophagic cell death via PI3K/Akt/mTOR signaling pathways in cortical neurons.

Authors:  Seung-Ju Yang; A Reum Han; Hye-Rim Choi; Kyouk Hwang; Eun-A Kim; Soo Young Choi; Sung-Woo Cho
Journal:  BMB Rep       Date:  2020-11       Impact factor: 4.778

7.  Puerarin Improves Diabetic Aorta Injury by Inhibiting NADPH Oxidase-Derived Oxidative Stress in STZ-Induced Diabetic Rats.

Authors:  Wenping Li; Wenwen Zhao; Qin Wu; Yuanfu Lu; Jingshan Shi; Xiuping Chen
Journal:  J Diabetes Res       Date:  2016-01-06       Impact factor: 4.011

8.  Oleanolic acid protects against oxidative stress‑induced human umbilical vein endothelial cell injury by activating AKT/eNOS signaling.

Authors:  Wei Zhang; Jian Feng; Biao Cheng; Qing Lu; Xiaoping Chen
Journal:  Mol Med Rep       Date:  2018-08-03       Impact factor: 2.952

9.  Anti-inflammatory effects of N-cyclooctyl-5-methylthiazol-2-amine hydrobromide on lipopolysaccharide-induced inflammatory response through attenuation of NLRP3 activation in microglial cells.

Authors:  Eun-A Kim; Kyouk Hwang; Ji-Eun Kim; Jee-Yin Ahn; Soo Young Choi; Seung-Ju Yang; Sung-Woo Cho
Journal:  BMB Rep       Date:  2021-11       Impact factor: 4.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.